Women aged 50 to 69 who take the most common type of HRT for five years or more run a 32 per cent risk of developing breast cancer s Oxford research says the therapy causes one in 20 cases.
Women aged 50 to 69 who take the most common type of HRT for five years or more run a 32 per cent risk of developing breast cancer s Oxford research says the therapy causes one in 20 cases.